Two lots of mar-amlodipine 5 mg tablets recalled
Official notice
7 Feb 2026
Last checked
7 Feb 2026
An official Health Canada notice concerns Two lots of mar-amlodipine 5 mg tablets recalled. Marcan Pharmaceuticals Inc. Is recalling two lots of MAR-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which they have identified as midodrine 2.5 mg tablets. MAR-Amlodipine is used to treat high blood pressure and chest pain in adults and children 6 years of age and older. The tablets are white to off-white, flat and eight-sided, with a line across the middle. One side has “210” and “5” printed on it, and the other side is blank. Midodrine 2.5 mg tablets are white, round, and marked with ‘M2’ on one side and have a line across the middle on the other side. Midodrine is used to treat low blood pressure and substituting amlodipine (5 mg) with midodrine (2.5 mg) can lead to serious side effects such as a dangerous increase in blood pressure, dizziness, fainting and organ damage. Patients with other conditions (e.g., pheochromocytoma, glaucoma, or hyperthyroidism) and those taking other medications could experience different side effects with varying levels of severity if they take the midodrine by mistake. Some patients may not experience any symptoms if their blood pressure is elevated, and may only know by measuring their blood pressure. Elevated blood pressure without symptoms can still result in significant harm to a patient. Children taking the wrong medication may face a higher risk of serious side effects and potential harm. Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to stop this issue from reoccurring. The Department will inform the public if any new health risks are identified. Published 2026-02-07.
What to do now
Immediately check your medication bottle to ensure it only contains MAR-Amlodipine 5 mg tablets. MAR-Amlodipine 5 mg tablets are white to off-white, flat and eight-sided, with a line across the middle. One side has "210" and "5" printed on it, and the other side is blank. Midodrine 2.5 mg tablets are white, round, and marked with 'M2' on one side and have a line down the middle on the other side. If your bottle contains any unusual tablets or if you are unsure, return it to your pharmacy. If you are unable to get a replacement immediately, continue taking your medication as directed but do not take the round tablets. Contact your health care professional or call 911 if you are dizzy, have unusually high blood pressure or slow heartbeats. Seek immediate medical attention if you have chest pain, a sudden headache, an inability to move or feel a part of your body, or impaired speech. If you have questions about this recall, contact Marcan Pharmaceuticals Inc. By calling 1-855-627-2261 or by emailing info@marcanpharma.com. Report any health product-related side effects or complaints to Health Canada. Additional information for health professionals: Health care professionals, such as pharmacists, should check packages and bottles labelled MAR-Amlodipine 5 mg (amlodipine besylate) before dispensing to make sure they do not contain midodrine 2.5 mg tablets. Report any unusual bottles or other issues to the company and Health Canada.
Recall number
81578
Official notice
2026-02-07
The hazard
The hazard
Marcan Pharmaceuticals Inc. Is recalling two lots of MAR-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which they have identified as midodrine 2.5 mg tablets. MAR-Amlodipine is used to treat high blood pressure and chest pain in adults and children 6 years of age and older. The tablets are white to off-white, flat and eight-sided, with a line across the middle. One side has “210” and “5” printed on it, and the other side is blank. Midodrine 2.5 mg tablets are white, round, and marked with ‘M2’ on one side and have a line across the middle on the other side. Midodrine is used to treat low blood pressure and substituting amlodipine (5 mg) with midodrine (2.5 mg) can lead to serious side effects such as a dangerous increase in blood pressure, dizziness, fainting and organ damage. Patients with other conditions (e.g., pheochromocytoma, glaucoma, or hyperthyroidism) and those taking other medications could experience different side effects with varying levels of severity if they take the midodrine by mistake. Some patients may not experience any symptoms if their blood pressure is elevated, and may only know by measuring their blood pressure. Elevated blood pressure without symptoms can still result in significant harm to a patient. Children taking the wrong medication may face a higher risk of serious side effects and potential harm. Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to stop this issue from reoccurring. The Department will inform the public if any new health risks are identified.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Lots
Other
Recall Numbers
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsAffected products
Affected products
Product 1
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Mar-amlodipine 5 MG Din 02371715. Contact: Marcan Pharmaceuticals Inc. Phone 1-855-627-2261.
Source & status
Source & status
Source
Tier
Category
App estimate
Recall details
Recall details
Recall number
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 7 Feb 2026. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.